The weight-loss drug semaglutide may help prevent heart attacks and other major adverse cardiac events (MACE) in people who are obese and have cardiovascular disease. heart...
When Tina Jacobson tried to take Ozempic to lose weight, her health insurance company denied coverage because she wasn't diabetic. Instead of paying more than $1,000...
Top Line Use of GLP-1 drugs such as semaglutide for weight loss has doubled over the past decade, but uptake among people with type 2 diabetes...
CLEVELAND, Ohio (WOIO) – More than 15 million Americans are using injectable medications like Ozempic and Wegoby to lose weight, according to a new poll, but...
$350 Genetic Test developed The study, by researchers at the Mayo Clinic in Rochester, Minn., and subsequently licensed to Phenomic Sciences, gave patients risk scores regarding...
About 3.6 million Medicare enrollees may be eligible for coverage for the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it costs Medicare...
Recent Comments